These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 22382219
1. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention. Shemirani H, Pourrmoghaddas M. Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):280-5. PubMed ID: 22382219 [Abstract] [Full Text] [Related]
2. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK. Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188 [Abstract] [Full Text] [Related]
3. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography. Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R. Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594 [Abstract] [Full Text] [Related]
4. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study. Alessandri N, Lanzi L, Garante CM, Tersigni F, Sergiacomi R, Petrassi M, Di Matteo A, Tufano F. Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661 [Abstract] [Full Text] [Related]
5. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. Marenzi G, Ferrari C, Marana I, Assanelli E, De Metrio M, Teruzzi G, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL. JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154 [Abstract] [Full Text] [Related]
7. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention. Zhang J, Fu X, Jia X, Fan X, Gu X, Li S, Wu W, Fan W, Su J, Hao G, Jiang Y, Xue L. Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292 [Abstract] [Full Text] [Related]
9. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial. Koc F, Ozdemir K, Kaya MG, Dogdu O, Vatankulu MA, Ayhan S, Erkorkmaz U, Sonmez O, Aygul MU, Kalay N, Kayrak M, Karabag T, Alihanoglu Y, Gunebakmaz O. Int J Cardiol; 2012 Mar 22; 155(3):418-23. PubMed ID: 21106264 [Abstract] [Full Text] [Related]
20. Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials. Duan N, Zhao J, Li Z, Dong P, Wang S, Zhao Y, Wang L, Wang H. Med Sci Monit; 2015 Jan 23; 21():292-7. PubMed ID: 25613017 [Abstract] [Full Text] [Related] Page: [Next] [New Search]